Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
11 July 2021 - 3420
The burden of carbapenem-resistant Acinetobacter species infections in Europe: a pooled analysis from the CARBAR study
Simon Goldenberg, S. Goldenberg (1), T. Chalk (2), E. Botelho-Nevers (3), J.P. Horcajada (4), T. Reason (2), S. Lopes (5), C. Longshaw (5), K. Tone (5), K. Gill (5)
11 July 2021 - 4363
Deleterious effect of non-expansion of CD8+ T cells in COVID-19 disease
Ana Pascual-Dapena, A. Pascual-Dapena (1, 2), I. Arnau-Barres (3), J. Soldado-Folgado (3), I. Arrieta (3), I. López-Montesinos (3), S. Gómez-Zorrilla (3), L. Sorli (3), X. Nogues (3), J. Pascual (3), J.P. Horcajada (3), R. Güerri-Fernández (3)
10 July 2021 - 4095
Application of a Clinical Outcome Prediction through-time (COP-tt) model in COVID-19 epidemic: utility in hospital resource management
Silvia Gómez-Zorrilla, S. Gómez-Zorrilla (1), I. López-Montesinos (1), P. Pomés (2), E. Perez (1), L. Sorli (1), E. Sendra (1), I. Arrieta-Aldea (1), R. Güerri-Fernández (1), S. Grau (1), J. Martinez-Roldan (1), A. Principe (1), J.P. Horcajada (1)
09 July 2021 - 3191
Clinical experience with tuberculosis and immune reconstitution-inflammatory syndrome in patients treated with anti-tumour necrosis factor-α
Maria Mar Arenas-Miras, M.M. Arenas-Miras, F. Sanchez, N. Jové-Caballé, J. Villar-García, I. Lopez-Montesinos, J.P. Horcajada
09 July 2021 - 1672
Analysis of safety from STRIVE phase II Trial of rezafungin treatment of candidaemia and/or invasive candidiasis: assessment of adverse events and laboratory values
George R. Thompson, G.R. Thompson (1), A. Soriano (2), P.M. Honore (3), J.P. Horcajada (4), A. Das (5), T. Sandison (5), P.G. Pappas (6)
09 July 2021 - 1738
Influence of prophylactic treatment on the quality of life and symptoms control in women with recurrent urinary tract infections
Maria Mar Arenas-Miras, M.D.M. Arenas Miras (1), M. Mendo-Esparza (2), I. Lopez-Montesinos (1), M. Montero (1), L. Sorlí (1), X. Durán-Jordá (3), J.P. Horcajada (1)
09 July 2021 - 3447
The burden of nosocomial pneumonia infections involving carbapenem-non-susceptible bacteria in Europe: the pooled results of the CARBAR study
Simon Goldenberg, S. Goldenberg (1), T. Chalk (2), E. Botelho-Nevers (3), J.P. Horcajada (4), T. Reason (2), S. Lopes (5), C. Longshaw (5), K. Tone (5), K. Gill (5)
09 July 2021 - 3396
Patients with confirmed or suspected carbapenem non-susceptible Gram-negative infections from the CARBAR part 2 study: UK, France, and Spain
Simon Goldenberg, S. Goldenberg (1), T. Chalk (2), E. Botelho-Nevers (3), J.P. Horcajada (4), T. Reason (2), S. Lopes (5), C. Longshaw (5), K. Tone (5), K. Gill (5)
09 July 2021 - 3175
The CARBAR part 1 study: a pooled analysis of the epidemiology data for UK, France and Spain
Simon Goldenberg, S. Goldenberg (1), T. Chalk (2), E. Botelho-Nevers (3), J.P. Horcajada (4), T. Reason (2), S. Lopes (5), C. Longshaw (5), K. Tone (5), K. Gill (5)
09 July 2021 - 1283
ESCAPE trial: preliminary data on the effect of vafidemstat treatment in the COVID-19 induced immune response in hospitalised patients
Mabel Arévalo, M. Arévalo (1), R. Ruíz-Rodríguez (1), L. Fernánde De Orueta (2), J. Sanz (3), B. Almirante (4), J.P. Horcajada (5), S. Gutiérrez (1), J. Xaus (1), C. Buesa (1)
09 July 2021 - 4811
Suboptimal ceftolozane/tazobactam (C/T) concentrations in continuous infusion could lead to the emergence of C/T resistance against Pseudomonas aeruginosa in an in vitro hollow fiber infection model
Maria Milagro Montero, M.M. Montero (1), S. Domene Ochoa (1), C. López Causapé (2), S. Luque (1), L. Sorli (1), I. López Montesinos (1), N. Campillo (1), E. Padilla (3), N. Prim (3), S. Grau (1), A. Oliver (2), J.P. Horcajada (1)
09 July 2021 - 3506
Increasing detection of carbapenemase genes directly on rectal swabs: a way of improving surveillance
Aida Ramirez, A. Ramirez (1), M. Vujadinovic (1), Y. Hoyos (1), M.M. Montero (2), L. Sorlí (2), A. Suárez (1), S. Díaz (1), A. Vilas (1), M. Herranz (3), C. González (3), J.P. Horcajada (2), N. Prim Bosch (1), E. Padilla (1)
09 July 2021 - 4936
Staggered versus simultaneous administration of meropenem and amikacin in combined therapy against extensively drug-resistant Pseudomonas aeruginosa: may dosing schedule influence the initial decrease in the bacterial load?
Berta Puig-Collderram, B. Puig-Collderram (1), C. Morros-Bernaus (1), J. Rovira-Plujà (1), S. Domene Ochoa (2), L. Sorlí (2), S. Luque (3), M.M. Montero (2), C. Segura (1), A. Oliver (4), J.P. Horcajada (2), S. Grau (3), E. Padilla (1), N. Prim (1)
09 July 2021 - 4459
Comparative plasma pharmacokinetics and pharmacodynamics of different surgical antimicrobial prophylactic regimens in patients undergoing total knee and hip arthroplasty (TKA/THA) against bacteria isolated from patients with TKA/THA prosthetic joint infec
Sonia Luque, S. Luque (1), A. Rivera (2), A. Gállego (3), C.S. Batista (2), N. Campillo (4), E. Navarrete (4), R. Altaba (2), A. Sánchez (2), I. Mur (3), L. Puig (5), X. Crusi (6), J.C. González (6), L. Sorlí (7), J.P. Horcajada (7), F. Navarro (2), N. Benito (3)
09 July 2021 - 2592
Pharmacokinetic study of colistin in patients with pneumonia caused by extensively drug-resistant Pseudomonas aeruginosa
Luisa Sorlí, L. Sorlí (1), S. Luque (2), D. Santana (3), X. Fernandez (2), N. Campillo (2), J. Gomez-Junyent (1), A. Benítez-Cano (4), S. Gómez-Zorrilla (1), R. Garcia (2), I. Lopez-Montesinos (1), M.D.M. Arenas (1), M. Montero (1), N. Prim (5), R. Güerri (1), S. Grau (2), J.P. Horcajada (1)
09 July 2021 - 4103
Optimal PK/PD target, efficacy and safety of daptomycin: a therapeutic drug monitoring retrospective monocentric analysis
Laura Río No, L. Río No (1), S. Luque (1, 2, 3), L. Sorlí (2, 3, 4, 5), N. Campillo (1, 2), N. Prim (6), M.E. Navarrete Rouco (1), R. Muñoz Bermudez (7, 8), A. Benitez-Cano (2, 9), P. Acín (1), A. Rodríguez Alarcón (1), M. Montero (2, 10), J.P. Horcajada (2, S. Grau (1
09 July 2021 - 4984
Use of SeptiCyte® RAPID  to assess the risk of ICU admission in COVID-19 patients
Max Hardy-Werbin, M. Hardy-Werbin (1), S. Gonzalez Gallardo (1), E. Torres (1), R. Rueda (1), I. Hannet (2), J. Kirk (2), T. Yager (2), K. Navalkar (2), M. Del Mar Arenas (1), I. Arrieta-Aldea (1), S. Castaneda (1), J. Gomez-Junyent (1), S. Gomez-Zorillas (1), R. Guerri (1), J.P. Horcajada Gallego (1), E. Letang (1), I. Lopez-Montesinos (1), M. Montero (1), I. Pelegrin (1), E. Sendra (1), L. Sorli (1), J. Villar-Garcia (1), B. Bellosillo Paricio (1)
23 September 2020 - P47
Clinical Outcome Prediction for resource management (COP-rm): real application to a COVID-19 epidemic.
Alessandro Principe, A. Principe, S. Gómez-Zorrilla, I. López-Montesinos, E. Perez, L. Sorli, P. Pomés, P. Medina, A. Márquez, J. Martínez-Roldán, R. Güerri-Fernández, J.P. Horcajada
23 September 2020 - P293
A nosocomial COVID-19 outbreak in a non-COVID-19 unit during the first epidemic wave in Spain
Maria Milagro Montero, M.M. Montero, C. Hidalgo, I. Lopez Montesinos, L. Sorli, J. Villar-Garcia, G.F. Roberto, M. Herranz, M. Crespo, M.D. Arenas Jimenez, J. Pascual, C. Gonzalez, J.P. Horcajada
23 September 2020 - P177
Lower baseline zinc levels are associated with poorer outcome in COVID-19
Robert Güerri-Fernández, I. Arnau-Barres, R. Güerri-Fernández, S. Gómez-Zorrilla, I. López-Montesinos, F. Sánchez, I. Arrieta, M.D.M. Arenas, J. Villar, M. Montero, L. Sorli, P. Capdevila, C. Sanchez Molina, J.P. Horcajada
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.